- The Federal Trade Commission (“FTC”) reached settlements with supplement company Quantum Wellness Botanical Institute, LLC and its officer (collectively “Quantum Wellness”) and Maria Gutierrez Veloso (“Veloso”) to resolve allegations that they deceptively marketed a pill as a cure-all for age-related conditions in violation of the FTC Act.
- In the complaint, the FTC alleges that first Veloso, then Quantum Wellness aggressively advertised ReJuventation, a pill containing amino acids and herbal extracts that they claimed – without substantiation – could reverse the aging process by increasing human growth hormone, and reverse a number of conditions including Alzheimer’s disease and wrinkles.
- The stipulated orders against Quantum Wellness and Veloso, among other things, enjoin them from making health claims that are not substantiated by scientific evidence, and impose partially suspended judgments totaling $3.4 million with required payments totaling $660,000 to the FTC, which the FTC may use to provide refunds to defrauded consumers.